Cellanyx Diagnostics
Boston, Massachusetts, United States
Live Cell In Vitro Cancer Diagnostics
Cellanyx is developing a prognostic central lab service for prostate cancer by leveraging lab-on-a-chip technology, novel biomarkers, and predictive algorithms. Current prostate cancer diagnostics are inadequate, lack sensitivity and prognostic value. Cellanyx is offering a predictive, sensitive, and cost effective solution to inform physicians at the radical prostatectomy decision point. Cellanyx's technology will improve the diagnostic process, increasing patient quality of life - significant